Brief introduction：An adjunct to chemotherapy agents to extend survival and to maintain remission after treatment for acute non-lymphocytic leukemia in adults.
Brief introduction：Deemed to have completed the Quality Consistency Evaluation; It is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer,and for treatment of patients with metastatic colorectal carcinoma, metastatic breast cancer, advanced or metastatic gastric cancer and combined adjuvant treatment after an operation (see Package Leaflet for details).
